David H. Rubin, MD (Content Reviewer)

Susan Sprich, PhD (Psychologist Reviewer)

Policy on Faculty and Provider Disclosure:

Disclosure Information 
In accordance with the disclosure policy of MGH Institute of Health Professions as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:                        

Ineligible Companies 
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit accme.org/standards.

Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. 

Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.

Planner Disclosures

The following planners have identified financial disclosures: 

Mary Colvin, PhD

Honorarium: Conference Organizer/Speaker: Parent Project Muscular Dystrophy

Honorarium: Speaker. Tourette Syndrome Association 

Continuing Education Course: American Psychological Association, American Academy of Pediatrics

Maurizio Fava, MD

https://mghcme.org/app/uploads/2021/07/MF-Disclosures-Lifetime-updated-July-2021.pdf

Oliver Freudenreich, MD, FAPM

Advisory Board: Avanir, Neurocrine Janssen, Janssen Alkermes Alkermes - CME Speaker and content developer

Consultant: Global Medical Education, Novartis Otsuka, Roche Integral - Medical writer, content developer, and editor

Advisor: Wolters-Kulwer UpToDate Elsevier MedScape Springer Verlag American Psychiatric Association

Jerrold Rosenbaum, MD

Co-Founder (Equity): Psy Therapeutics Inc.

Co-Founder (Equity): Sensorium Therapeutics Inc. 

Advisor (Equity): The Real, Inc., Odin, Terran Biosciences

Scott Beach, MD

Honorarium (Speaker Fee): Psychopharmacology Institute

Susan Sprich, PhD

Royalties (Co Author): Oxford University Press

Royalties (Co-Edited Book): Springer

Associate Editor: "Cognitive and Behavioral Practice" Association for Behavioral and Cognitive Therapies (ABCT)

Theodore Stern, MD 

Royalties (Editor): Elsevier - Psychiatric textbook 

Sabine Wilhelm, PhD

Advisor (Equity): Koa Health - Scientific Advisory Board 

Royalties: Book Author - New Harbinger Publications, Guilford Publications, Oxford Associated Press, Springer 

Honorarium: International OCD Foundation, Tourette Association of America, and the Centers for Disease Control and Prevention 

Honorarium: Scientific-Advisory Board: One-Mind PsyberGuide

The following planners and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:

David Rubin, MD

Jane Pimental, MPH

Jennifer Gatchel, MD, PhD

Randi Schuster, PhD, Assistant Professor, Harvard Medical School, Center for Addiction Medicine, Massachusetts General HospitalRandi Schuster, PhD 

Committee Members/Planners:

• Maurizio Fava, MD, Psychiatrist-in-Chief, Director, Division of Clinical Research / MGH Research Institute, Executive Director, Clinical Trials Network & Institute (CTNI), Massachusetts General Hospital, Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School

• Molly Colvin, PhD ABPP; Director MGH Learning and Emotional Assessment Program (LEAP); Assistant Professor of Psychology, Harvard Medical School

• John Herman, MD, Associate Chief of the Dept. of Psychiatry at Massachusetts General Hospital, Associate Professor of Psychiatry at Harvard Medical School.  Medical Director of Partners Employee Assistance Program

• Jerrold Rosenbaum, MD, Psychiatrist-in-Chief Emeritus, Director, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Stanley Cobb Professor of Psychiatry, Harvard Medical School

• Scott Beach, MD, FACLP, Program Director, MGH/McLean Adult Psychiatry Residency, Psychiatrist, Avery D. Weisman Psychiatric Consultation Service, MGH, Assistant Professor of Psychiatry, Harvard Medical School

• Theodore Stern, MD, Chief Emeritus, Avery D. Weisman Psychiatry Consultation Service, Director, Thomas P. Hackett Center for Scholarship in Psychosomatic Medicine, Director, Office for Clinical Careers, Massachusetts General Hospital; Ned H. Cassem Professor of Psychiatry in the field of Psychosomatic Medicine, Harvard Medical School; Editor-in-Chief, Psychosomatics

• Oliver Freudenreich, MD, FACLP, Co-Director, MGH Schizophrenia Clinical and Research Program, Department of Psychiatry, Associate Professor of Psychiatry, Harvard Medical School

• Sabine Wilhelm, PhD, Chief of Psychology, Department of Psychiatry, Massachusetts General Hospital (MGH), Director, OCD and Related Disorders Program, MGH Professor of Psychology, Harvard Medical School (HMS)